Our Team

FruitVaccine Family

Dennis E. Buetow, Ph.D. (Co-Founder/President) 

Dr. Buetow served at the National Institutes of Health (NIH) and at Baltimore City Hospitals in Maryland from 1959 to 1965. Since 1965, he was employed as a Professor in the Department of Molecular and Integrative Physiology at the University of Illinois at Urbana-Champaign, USA (UIUC). He was Head of this Department from 1983-1988 and Interim Head from 1991-1992. Currently, he is Professor Emeritus in this Department where he continues to do research on a daily basis. He received his PhD in 1959 from the University of California, Los Angeles (UCLA). Dennis was elected as a Fellow of the Gerontological Society and of the American Association for the Advancement of Science. He has served on numerous national and university committees and was Editor for the Academic Press series “Cell Biology, a Series of Monographs” among over 100 other book chapters and journal articles on his research. He has presented numerous seminars and addresses in the US, Europe and Asia.

S. Indu Rupassara, Ph.D. (Co-Founder/CEO/Vice-President)

LinkedIn and Google Scholar

Dr. Rupassara’s multidisciplinary research expertise includes biotechnology, microbiology, immunology, analytical biochemistry, metabolomics and other ‘omics’ technologies, using a wide array of biological systems such as humans, small (experimental) animals, plants, and microorganisms. She has been previously employed as a Researcher, Consultant, Metabolomist/Mass Spectrometrist, Lab Director, and as a Lecturer, in the US, Australia, and Sri Lanka. Indu received her MBA (2019), and PhD (2008, in Metabolomics/Biotechnology) from the UIUC. She also received MS degrees from the UIUC and University of Sydney, Australia, in Microbiology and Biochemistry. Her BSc degree is from the University of Peradeniya, Sri Lanka. Indu has presented talks in conferences in the US, Europe, Australia, and Asia, in addition to publishing her research in journal articles and book-chapters.

John Kindt Jr. (Technical and Business Analyst)

John Kindt serves as a business and technical specialist with a decade of experience in the financial services industry and University of Illinois at Urbana Champaign (UIUC) system. He is assisting FruitVaccine’s R&D efforts through data analysis, forecasting, and funding applications, and evaluating the feasibility of novel processes and production methods. John also performs market analysis and helps manage the development of a unique logistic FruitVaccine ecosystem. John received his MBA from the Gies College of Business at UIUC, and his BS degree in Finance from Eastern Illinois University.

Research Advisors/Consultants/Collaborators

Edwin G. Moore, Ph.D.

Dr. Moore brings 30 years of biopharmaceutical, pharmaceutical, and clinical diagnostic industry experience from global companies, Baxter Healthcare Corp and Abbott Laboratories, in R&D product development. During his career, he has held various roles in CMC pre-clinical product development for recombinant therapeutic proteins and for IV parenteral small molecule products in Analytical Method Development, Stability Testing, Formulation, as well as leading overall pre-clinical product development for a recombinant therapeutic protein product. Ed also mentors start-up companies at EnterpriseWorks, the University of Illinois incubator. Ed has a PhD in Physical Biochemistry from Cornell University, Ithaca, NY, and received a BS in Biochemistry from the University of Illinois, Urbana-Champaign (UIUC).
More about Ed

Charles J. Arntzen, Ph.D.

Dr. Arntzen is an elected member of the U.S. National Academy of Sciences and the National Academy of Inventors. He received the USDA Award for Superior Service, and served as chairman of the National Biotechnology Policy Board of the National Institutes of Health. Dr. Arntzen’s primary research interests have been in plant molecular biology and protein engineering, as well as the utilization of plant biotechnology for enhancement of food quality and value, for expression of pharmacologically active products in transgenic plants. He has been recognized as a pioneer in the development of plant-based vaccines for human disease prevention, and for disease prevention in animal agriculture.
More about Charles

M. Kathleen Buetow, Ph.D.

Dr. Buetow has been a Pediatric Physician on the staff of Carle Foundation Hospital and a member of the Carle Physician Group in Urbana, Illinois since 1965 and served on Carle’s Immunization Committee. As a Carle staff member she has also served as Head of the Department of Pediatrics at the University of Illinois College of Medicine at Urbana-Champaign from 1986-2007. Kathleen received an MD from the University of Maryland in 1954 and subsequently did a Pediatric Residency at Baltimore City Hospitals and Cincinnati Children’s Hospital. She then returned to Baltimore to pursue a Doctor of Public Health degree at Johns Hopkins School of Hygiene and Public Health with her thesis work on the topic of Neonatal Mortality. She became a diplomat of the American Academy of Pediatrics (AAP) in 1959, and has been a member of the AAP since then. She has been involved for the past 20 years on a state Child Death Review Team which seeks to identify and remedy problems associated with Child Mortality.
More about Kathleen

Hugh S. Mason, Ph.D.

Dr. Mason was the first to publish peer-reviewed work on the use of plants for production of vaccine antigens, showing expression of authentic hepatitis B surface antigen in tobacco (Mason et al., 1992). He was a leader in this field for many years and continue to publish work in plant-based vaccines (Kim et al., 2015). With funding from NIH-NIAID, Dr. Mason focused on oral delivery of vaccines for enteric diseases including Norwalk virus (Mason et al., 1996) and enterotoxic E. coli (Haq et al., 1995), and demonstrated oral immunogenicity in mice after ingestion of transgenic potato tuber.
More about Hugh

Brenda Anne Wilson, Ph.D.

Dr. Wilson is a Professor of Microbiology and Associate Director of Undergraduate Education in the School of Molecular & Cellular Biology, College of Liberal Arts and Sciences, with a joint appointment in Pathobiology, College of Veterinary Medicine, at the UIUC. She is also an Inaugural Professor in the Carle Illinois College of Medicine. Brenda earned her B.A. degree in Biochemistry and German from Barnard College, Columbia University, in New York, and her M.S.-Ph.D. degrees in Chemistry from the Johns Hopkins University in Baltimore, Maryland, where she studied β-lactam antibiotics. She also studied on bacterial protein toxins as a microbiology postdoctoral fellow at Harvard Medical School. Her current research focuses on host-microbe interactions: structure and function and molecular evolution of bacterial protein toxins, their molecular interactions with and biochemical effects on eukaryotic host target cells; developing novel post-exposure antitoxin therapeutics and toxin-based therapeutic delivery platforms; and exploiting comparative and functional genomic technologies to study extensively drug resistant bacteria and microbiomes in health and disease.
More about Brenda

Erik Nelson, Ph.D.

Dr. Nelson received his BSc (major: zoology, minor: chemistry) and PhD in comparative endocrinology from the University of Calgary. He then moved to Duke University School of Medicine to pursue postdoctoral studies specializing in pharmacology and cancer biology. In 2014, he was recruited to the University of Illinois at Urbana-Champaign as an Assistant Professor of Molecular and Integrative Physiology. His research program is focused on how hormones and cholesterol metabolism impact breast and ovarian cancer progression. In recognition of his research, Dr. Nelson has been awarded the Government of Alberta Queen Elizabeth II Graduate Scholarship, a Department of Defense Breast Cancer Research Program Postdoctoral Fellowship Award, and a National Cancer Institute Pathway to Independence Award.
More about Erik

Jagdeep S. Sandhu, Ph.D.

Dr. Sandhu obtained his PhD from the University of Cambridge, UK, in 1996. He conducted postgraduate research on transfer of the RSV fusion-protein into plants, at the University of Illinois at Urbana-Champaign (1996-2000, in Buetow-lab), and then as a biotechnologist at the Punjab Agricultural University, India, where he is employed at the present time.
More about Jagdeep

Jose O. Solbiati, Ph.D.

Dr. Solbiati is currently conducting research at the University of Florida. He also served at the University of Illinois for over 10 years after being employed both in Argentina and Spain upon completion of his PhD in Argentina. Dr. Solbiati has been collaborating with Dr. Dennis Buetow and Dr. Indu Rupassara on the research related to genetic engineering to stabilize the RSV gene.
More about Jose

Daniel McKim, Ph.D.

Dr. McKim is an assistant professor in the Department of Animal Science at the University of Illinois Urbana-Champaign. He completed his doctoral and postdoctoral training at The Ohio State University Wexner Medical Center with a focus on neuroendocrine regulation of hematopoiesis using mouse models. Dr. McKim currently runs a research lab studying the interactions between lifestyle factors, hematopoiesis, and chronic health conditions. Dr. McKim contributes to the FruitVaccine team with expertise in animal modeling for immunology research and employs relevant techniques including flow cytometry, single cell transcriptomics, and functional assays.
More about Daniel and profile

Indika Kahanda, Ph.D.

Dr. Indika Kahanda is an Assistant Professor in the Gianforte School of Computing at Montana State University, where he directs the bioinformatics, biomedical informatics, and medical informatics lab. He received his Ph.D. in Computer Science from Colorado State University in 2016 in the area of Bioinformatics, a Master of Science in Computer Engineering from Purdue University in 2010, and a Bachelor of Science in Computer Engineering from University of Peradeniya, Sri Lanka in 2007. His research interests lie in the areas of Bioinformatics, Biomedical Informatics, and Medical Informatics. He focuses on the application of machine learning and natural language processing techniques to solve problems involving large-scale biological, molecular, and biomedical data.
More about Indika

Other Advisors